Tumor Volume Kinetic Analyses Might Explain Excellent Prognoses in Young Patients with Papillary Thyroid Carcinoma
Table 1
Clinical features of the 20 pediatric or adolescent patients with papillary thyroid carcinoma.
Clinical and biochemical features
Age (years)
18 (12–19)
Male/female
3/17
Tumor size (mm)
16.5 (7–44)
cN0 or pN0/pN1a/pN1b (cases)
7/6/7
MX/M0/M1 (cases)
1/19/0
Follow-up period before surgery (months)
4.5 (3–60)
Cases underwent surgery
17
3 months after diagnosis
7
4 months after diagnosis
3
5 months after diagnosis
3
6 months after diagnosis
1
7 months after diagnosis
1
19 months after diagnosis
1
40 months after diagnosis
1
Cases followed without surgery
3
30 months after diagnosis
1
51 months after diagnosis
1
60 months after diagnosis
1
TV-DR (/year)
0.29 (−1.21–1.89)
hTV-DR (/year)
1.71 (1.48–2.66)
Values indicate median (ranges) and number of cases. TV-DR: tumor volume-doubling rate; hTV-DR: hypothetical tumor volume-doubling rate before presentation.
